SCHEMBL22097015

SCHEMBL22097015

Cc1cc2c3cc(-c4nc(-c5ccccc5)nc(-c5cc(-n6c7ccccc7c7ccccc76)cc(-n6c7ccccc7c7ccccc76)c5)n4)ccc3c3c(ccc4c5ccccc5n(-c5ccccc5)c43)c2cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ATM Q13315 1/20 0.38
PTGER4 P35408 1/20 0.35
RXFP1 Q9HBX9 2/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 2/20 0.32
AVPR1A P37288 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RXRA P19793 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
MAPK1 P28482 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPY5R Q15761 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096944 0.95 L3MBTL1 (0.39) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL22097157 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL22097074 0.88 L3MBTL1 (0.42) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL22097075 0.88 L3MBTL1 (0.42) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL22097262 0.87 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL22097203 0.87 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL23626900 0.86 L3MBTL1 (0.42) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL12690940 0.84 L3MBTL1 (0.50) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL16674358 0.83 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4RXFP1
SCHEMBL26841888 0.83 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885KDM4E 1846/4885ATM 3884/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885KDM4E 1846/4885ATM 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.